|
|
 | | | |
- close
- close
- close
- close
Rexnord Corporation (RXN) |
StreetInsider.com
Apr 10
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Equity+Offerings/Rexnord+%28RXN%29+Files+67.9M+Common+Shelf+for+Selling+Holders/8243711.html for the full story.
StreetInsider.com
Feb 12
Comment
* Rexnord (NYSE: RXN) has initiated a review of strategic alternatives to enhance shareholder value and has engaged Goldman, Sachs and Co. to serve as its financial adviser in that process. The alternatives considered could include the possible...
StreetInsider.com
Feb 11
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Stock+Buybacks/Streetinsider.com+After-Hours+Movers+211%3A+%28RXN%29+%28NCLH%29+%28LGF%29+Higher%3B+%28ORIG%29+%28KOS%29+%28HCA%29+Lower+%28more...%29/8081931.html for the full story.
MarketWatch
Feb 11
Comment
Shares of Lions Gate Entertainment climb after the movie and television studio says it swung to a profit for its third quarter. Ball-bearings manufacturer Rexnord also sees its stock climb after saying it launched a review of strategic alternatives.
StreetInsider.com
Feb 11
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Rexnord+%28RXN%29+to+Explore+Strategic+Alternatives%3B+Taps+Goldman+to+Advise/8080562.html for the full story.
StreetInsider.com
Feb 11
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Rexnord+%28RXN%29+Misses+Q3+EPS+by+1c%3B+Guides+Q4+Revs/8080546.html for the full story.
Benzinga
Feb 7
Comment
BMO Capital Markets downgraded Rexnord (NYSE: RXN) from Outperform to Market Perform and maintained a $21.00 price target.
BMO Capital Markets commented, "We are downgrading Rexnord to Market Perform from Outperform as we believe the shares...
StreetInsider.com
Nov 7
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Rexnord+%28RXN%29+Tops+Q2+EPS+by+4c/7852359.html for the full story.
Wall Street Journal
Oct 4
Comment
Plastic-packaging manufacturer Berry Plastics Group fell in its public-trading debut, a poor start for the week's biggest IPO. Regulus Therapeutics rose post-IPO.
Benzinga
Aug 9
Comment
Bank of America initiated its Buy rating on Rexnord Corporation (NYSE: RXN) with a Neutral rating and a price objective of $18.
Bank of America commented, "Rexnord is a diversified industrial company focused on two product platforms: Process &...
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
This company completed an initial public offering (IPO) of its stock in 2010. View articles that reference this company. Recent IPOs: Globe Specialty Metals • LogMeIn • Invesco Mortgage Capital • Medidata • Chemspec |
Rexnord Corporation (NYSE:RXN)
Business Overview
New Updates
The company's initial public offering of stock on the NYSE occurred on March 28, 2012. The company offered 23.7M shares each for $18. This was at the low end of the initial price range of $18-$20. The deal raised a total of approximately $426M. The lead mangers of the deal were BofA Merrill Lynch, Goldman, Credit Suisse, Deutsche Bank, and Barclays.[1]
Trends & Forces
| |||||||
